← Back to home

EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS

Clinical trials for EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS explained in plain language.

Never miss a new study

Get alerted when new EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS trials appear

Sign up with your email to follow new studies for EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First human test for potential breast cancer drug begins

Knowledge-focused Completed

This early-stage study tested a new drug called Orialpha (BD-C) in 15 healthy adults to check its safety. The main goal was to find the highest dose people can take without serious side effects. This is the first step in research that could one day lead to a treatment for breast …

Matched conditions: EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS

Phase: PHASE1 • Sponsor: Oriplantee Company Limited • Aim: Knowledge-focused

Last updated Mar 23, 2026 15:16 UTC

EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS

Get alerted when new EVALUATE THE SAFETY PROFILE AND TOLERABILITY OF ORIALPHA IN HEALTHY ADULT VOLUNTEERS trials appear

First human test for potential breast cancer drug begins